Komori
Adjuvant Holdings (4929) · FactLower full-year R&D expenses

Increase in R&D expenses

First written in FY2016. . Latest entry: FY2026.

34entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2016 – FY20262016: 320162017: 420172018: 320182019: 420192020: 420202021: 320212022: 420222023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

90 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Lower full-year R&D expensesAnnual report

    「R&D expenses for the consolidated fiscal year were ¥119 million.」

    Full-year R&D expenses were ¥119 million, down from ¥146 million in the previous fiscal year.
  2. FY2026-H1Decline in first-half research and development expensesAnnual report

    「The total R&D expenses of the Group for the current six-month period of the consolidated fiscal year were ¥58 million.」

    First-half R&D expenses were ¥58 million, down from ¥72 million in the same period of the previous year.
  3. FY2025-H1Decline in first-half research and development expensesAnnual report

    「The total R&D expenses of the Group for the current six-month period of the consolidated fiscal year were ¥72 million.」

    First-half R&D expenses were ¥72 million (¥72.786 million in the financial statements), down from ¥98.630 million in the same period of the previous year.
  4. FY2025-Q1First-quarter research and development expenses of ¥38 millionAnnual report

    「The total R&D expenses of the Group for the current first quarter of the consolidated fiscal year were ¥38 million.」

    Research and development expenses for the cumulative first quarter were disclosed as ¥38 million.
  5. FY2024-Q3Third-quarter R&D expenses: ¥137 millionAnnual report

    「Total R&D expenses for the current nine-month period of the consolidated fiscal year were ¥137 million.」

    Cumulative R&D expenses for the third quarter were ¥137 million, up from ¥136 million in the same period of the previous year.
  6. FY2024-Q2First-half R&D expenses: ¥98 millionAnnual report

    「The total R&D expenses of the Group for the current six-month period of the consolidated fiscal year were ¥98 million.」

    First-half R&D expenses were ¥98 million, up from ¥89 million in the same period of the previous year.
  7. FY2024-Q1First-quarter R&D expenses: ¥46 millionAnnual report

    「The total R&D expenses of the Group for the current first quarter of the consolidated fiscal year were ¥46 million.」

    Cumulative R&D expenses for the first quarter were ¥46 million, up from ¥35 million in the same period of the previous year.
  8. FY2023Increase in full-year R&D expensesAnnual report

    「As a result, R&D expenses for the consolidated fiscal year were ¥181 million.」

    Full-year R&D expenses were ¥181 million, up from ¥173 million in the previous fiscal year.
  9. FY2023-Q3Increase in R&D expenses for the first 3 quartersAnnual report

    「Total R&D expenses for the current nine-month period of the consolidated fiscal year were ¥136 million.」

    Cumulative R&D expenses for the third quarter were ¥136 million, up from ¥120 million in the same period of the previous year.
  10. FY2023-Q2First-half R&D expenditure increasedAnnual report

    「The total R&D expenses of the Group for the current six-month period of the consolidated fiscal year were ¥89 million.」

    First-half R&D expenses were ¥89 million, up from ¥75 million in the same period of the previous year.
  11. FY2023-Q1First-quarter R&D expenses: ¥44 millionAnnual report

    「The total R&D expenses of the Group for the current first quarter of the consolidated fiscal year were ¥44 million.」

    Cumulative R&D expenses for the first quarter were ¥44 million, up from ¥35 million in the same period of the previous year.
  12. FY2022Full-year research and development expenses of ¥173 millionAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥173 million.」

    Full-year R&D expenses were ¥173 million, up from ¥151 million in the previous fiscal year.
  13. FY2022-Q3Third-quarter research and development expenses of ¥120 millionAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥120 million.」

    Research and development expenses for the cumulative third quarter were disclosed as ¥120 million.
  14. FY2022-Q1First-quarter research and development expenses of ¥35 millionAnnual report

    「Total research and development expenses for the Group during the cumulative first quarter were ¥35 million.」

    Total research and development expenses for the cumulative first quarter were ¥35 million, down from ¥38 million in the same period of the previous year.
  15. FY2021Full-year research and development expenses of ¥151 millionAnnual report

    「As a result, research and development expenses for the consolidated fiscal year were ¥151 million.」

    Full-year research and development expenses were ¥151 million, down from ¥161 million in the previous fiscal year.
  16. FY2021-Q3Third-quarter research and development expenses of ¥112 millionAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥112 million.」

    Research and development expenses for the cumulative third quarter were disclosed as ¥112 million.
  17. FY2021-Q2First-half research and development expenses of ¥75 millionAnnual report

    「Total research and development expenses for the Group during the cumulative second quarter were ¥75 million.」

    Research and development expenses for the cumulative second quarter were disclosed as ¥75 million.
  18. FY2021-Q1First-quarter research and development expenses of ¥38 millionAnnual report

    「Total research and development expenses for the Group during the cumulative first quarter were ¥38 million.」

    Research and development expenses for the cumulative first quarter were disclosed as ¥38 million.
  19. FY2020Increase in full-year R&D expensesAnnual report

    「As a result, research and development expenses for the consolidated fiscal year were ¥161 million.」

    Full-year research and development expenses were ¥161 million, up from ¥146 million in the previous fiscal year.
  20. FY2020-Q3Third-quarter research and development expenses of ¥121 millionAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥121 million.」

    Research and development expenses for the cumulative third quarter were disclosed as ¥121 million.
  21. FY2020-Q2First-half research and development expenses of ¥78 millionAnnual report

    「Total research and development expenses for the Group during the cumulative second quarter were ¥78 million.」

    Research and development expenses for the cumulative second quarter were disclosed as ¥78 million.
  22. FY2020-Q1Quarterly research and development expenses of ¥41 millionAnnual report

    「Total research and development expenses for the Group during the cumulative first quarter were ¥41 million.」

    Research and development expenses for the cumulative first quarter were disclosed as ¥41 million.
  23. FY2019Decline in R&D ExpensesAnnual report

    「As a result, research and development expenses for the consolidated fiscal year were ¥146 million.」

    Full-year research and development expenses were ¥146 million, down from ¥156 million in the previous fiscal year.
  24. FY2019-Q3Third-quarter research and development expenses of ¥106 millionAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥106 million.」

    Research and development expenses for the cumulative third quarter were disclosed as ¥106 million.
  25. FY2019-Q1Quarterly research and development expenses of ¥40 millionAnnual report

    「Total research and development expenses for the Group during the cumulative first quarter were ¥40 million.」

    Research and development expenses for the cumulative first quarter were disclosed as ¥40 million.
  26. FY2018Increase in R&D ExpensesAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥156 million.」

    Full-year research and development expenses were ¥156 million, up from ¥142 million in the previous fiscal year.
  27. FY2018-Q3Research and development expenses of ¥114 millionAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥114 million.」

    Research and development expenses for the cumulative third quarter were disclosed as ¥114 million.
  28. FY2018-Q2First-half research and development expenses of ¥73 millionAnnual report

    「Total research and development expenses for the cumulative second quarter were ¥73 million.」

    Research and development expenses for the cumulative second quarter were disclosed as ¥73 million.
  29. FY2018-Q1Quarterly research and development expenses of ¥36 millionAnnual report

    「Total research and development expenses for the Group during the cumulative first quarter were ¥36 million.」

    Research and development expenses for the cumulative first quarter were disclosed as ¥36 million.
  30. FY2017Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses for the consolidated fiscal year were ¥142 million.」

    Full-year research and development expenses were ¥142 million, up from ¥110 million in the previous fiscal year.
  31. FY2017-Q3Research and development expenses of ¥108 million disclosedAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥108 million.」

    Research and development expenses for the cumulative third quarter were disclosed as ¥108 million.
  32. FY2017-Q2Increase in R&D ExpensesAnnual report

    「Total research and development expenses for the cumulative second quarter were ¥76 million.」

    Research and development expenses for the cumulative second quarter were disclosed as ¥76 million, up from ¥42 million in the same period of the previous year.
  33. FY2017-Q1Disclosure of quarterly R&D expensesAnnual report

    「Total research and development expenses for the Group during the cumulative first quarter were ¥33 million.」

    Research and development expenses for the cumulative first quarter were disclosed as ¥33 million.
  34. FY2016First statedAnnual report

    「As a result, research and development expenses for the consolidated fiscal year were ¥110 million.」

    Research and development expenses increased from ¥54 million in the previous year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Adjuvant Holdings's next results are scheduled for 2026-10-21. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in R&D expenses | ADJUVANT HOLDINGS CO.,LTD. (4929) | Komori